Sep 18, 2015

NICE Recommends Chugai’s RoACTEMRA^® (tocilizumab) as Monotherapy for Treatment of Severe Rheumatoid Arthritis

Home
About Chugai
News
NICE Recommends Chugai’s RoACTEMRA® (tocilizumab) as Monotherapy for Treatment of Severe Rheumatoid Arthritis

You are now moving to an external website.